No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Post-induction chemotherapy Epstein-Barr virus DNA is an effective prognostic indicator for nasopharyngeal carcinomas

byTeddy Guo

September 16, 2021

in StudyGraphics

Reading Time: 1 min read

Wellness Check: Sleep

RelatedReports

StudyGraphics

#VisualAbstract: Adjuvant PD-1 Blockade With Camrelizumab Improves Survival in Nasopharyngeal Carcinoma

March 26, 2025

StudyGraphics

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

March 24, 2025

Adaptive interim PET-CT guides treatment for advanced Hodgkin’s lymphoma

Oncology

High incidence of post-transplant lymphoproliferative disorder in Epstein-Barr virus-seronegative kidney recipients

January 27, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Jamie Foxx Back in Action, Paracetamol for Pain, FDA Against Addictive Vape Flavours, and Coffee and Tea, Beyond Caffeine:

January 7, 2025

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Detection of pathogenic genetic variants in early-onset atrial fibrillation

$#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas$

#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports